World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
22276
World Ranking
8983
National Ranking
237

Joop H. Jansen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Joop H. Jansen sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 337 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Joop H. Jansen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Joop H. Jansen sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Joop H. Jansen is affiliated with Radboud University in the Netherlands and has contributed extensively to the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their research mainly focuses on hematology, genetics, immunology, molecular biology, and cancer research, with a significant body of work dedicated to acute myeloid leukemia and related disorders.

The scientist's recent publications cover a variety of topics related to hematological malignancies and molecular diagnostics. Notable recent papers include:

  • "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms," 2022, published in Leukemia
  • "Molecular International Prognostic Scoring System for Myelodysplastic Syndromes," 2022, published in NEJM Evidence
  • "Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes," 2020, published in Nature Medicine
  • SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS," 2020, published in Blood
  • "In vitro capture and characterization of embryonic rosette-stage pluripotency between naive and primed states," 2020, published in Nature Cell Biology

Joop H. Jansen frequently publishes in the following venues:

  • Blood
  • HemaSphere
  • Leukemia
  • Blood Advances
  • Leukemia Research

Their most frequent collaborators include Bert A. van der Reijden, Aniek O. de Graaf, Arjan A. van de Loosdrecht, Luca Malcovati, and Harry Dolstra. These collaborations reflect sustained research partnerships mainly in hematological and molecular studies.

The scientist's research covers several key topics within hematology and molecular oncology such as:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • Epigenetics and DNA Methylation
  • Cancer Genomics and Diagnostics
  • Acute Lymphoblastic Leukemia Research
  • CAR-T Cell Therapy Research

The breadth of Joop H. Jansen's work spans the subfields of hematology, genetics, immunology, molecular biology, and cancer research, indicating a comprehensive approach to understanding blood cancers and their underlying biology, clinical features, and therapeutic strategies.

Best Publications

  • Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

    Gorica Nikoloski;Saskia M C Langemeijer;Roland P Kuiper;Ruth Knops

  • Acquired mutations in TET2 are common in myelodysplastic syndromes

    Saskia M C Langemeijer;Roland P Kuiper;Marieke Berends;Ruth Knops

  • Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells

    Karsten Weis;Sophie Rambaud;Catherine Lavau;Joop Jansen

  • Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    Luca Malcovati;Eva Hellström-Lindberg;David Bowen;Lionel Adès

  • Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study

    Daniel Cilloni;Aline Renneville;Fabienne Hermitte;Robert Kerrin Hills

  • Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells

    Ehsan Habibi;Arie B. Brinkman;Julia Arand;Leonie I. Kroeze

  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Elsa Bernard;Yasuhito Nannya;Robert P. Hasserjian;Sean M. Devlin

  • The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor–Mediated Cross-Linking

    Marije B Overdijk;J H Marco Jansen;Maaike Nederend;Jeroen J Lammerts van Bueren

  • The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.

    Bryan Linggi;Carsten Müller-Tidow;Louis van de Locht;Ming Hu

  • Transcriptional diversity during lineage commitment of human blood progenitors

    Lu Chen;Lu Chen;Lu Chen;Myrto Kostadima;Myrto Kostadima;Myrto Kostadima;Joost H. A. Martens;Giovanni Canu;Giovanni Canu

  • Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

    Arjan A. van de Loosdrecht;Canan Alhan;Marie Christine Béné;Matteo G. Della Porta

  • Response to interferon alfa-2b in a patient with systemic mastocytosis.

    Hanneke C. Kluin-Nelemans;Joop H. Jansen;Henk Breukelman;Bert G Wolthers

  • Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data.

    Sarah Sandmann;Aniek O. de Graaf;Mohsen Karimi;Bert A. van der Reijden

  • Impairment of DNA Methylation Maintenance Is the Main Cause of Global Demethylation in Naive Embryonic Stem Cells

    Ferdinand von Meyenn;Mario Iurlaro;Ehsan Habibi;Ning Qing Liu

  • SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

    Luca Malcovati;Kristen Stevenson;Elli Papaemmanuil;Donna Neuberg

  • Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients

    Harry Dolstra;Mieke W.H. Roeven;Jan Spanholtz;Basav N. Hangalapura

  • Gfi1 and Gfi1b: key regulators of hematopoiesis

    L T van der Meer;J H Jansen;B A van der Reijden

  • High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial

    Roelof Willemze;Stefan Suciu;Giovanna Meloni;Boris Labar

  • A dominant-negative GFI1B mutation in the gray platelet syndrome

    Davide Monteferrario;Nikhita A Bolar;Anna E Marneth;Konnie M Hebeda

  • Clonal evolution in myelodysplastic syndromes

    Pedro da Silva-Coelho;Pedro da Silva-Coelho;Leonie I. Kroeze;Kenichi Yoshida;Theresia N. Koorenhof-Scheele

Frequent Co-Authors

Theo de Witte
Theo de Witte Radboud University
Harry Dolstra
Harry Dolstra Radboud University
Martin Dugas
Martin Dugas Heidelberg University
Sergio Amadori
Sergio Amadori University of Rome Tor Vergata
Edo Vellenga
Edo Vellenga University Medical Center Groningen
Stefan Suciu
Stefan Suciu European Organisation for Research and Treatment of Cancer
Joost H.A. Martens
Joost H.A. Martens Radboud University
Eva Hellström-Lindberg
Eva Hellström-Lindberg Karolinska University Hospital
Tarik Möröy
Tarik Möröy University of Montreal
Seishi Ogawa
Seishi Ogawa Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry in the USA opens doors to diverse careers and further study options. Many students explore related fields to boost their expertise and marketability—especially as flexible, online degree programs have become more accessible and affordable.

If you are interested in nutrition, pursuing one of the fastest nutrition degree programs online could be a smart move, letting you accelerate your education and enter the field quickly. Likewise, combining scientific skills with business acumen through an affordable online mba healthcare management program can lead to leadership roles in biotech, healthcare, or research organizations.

For those interested in the administrative side of healthcare, medical coding is another viable pathway. Understanding the differences in certification is essential—our comparison of cpc vs ccs outlines credentials, costs, and salary prospects. To learn more about job outlooks and incomes, explore current medical.coding salary trends.

Exploring these related degrees and certifications can help maximize your career opportunities in areas ranging from laboratory research to healthcare management and coding.

Best Scientists Citing Joop H. Jansen

Trending Scientists

Recently Published Articles